Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News JOHNSON & JOHNSON JNJ

Healthcare
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more

Recent & Breaking News (NYSE:JNJ)

Johnson & Johnson Reports 2014 First-Quarter Results:

PR Newswire April 15, 2014

Gilead's (GILD) Blockbuster Hepatitis-C Drug Sovaldi Steps Up Race

Equities.com April 7, 2014

OxySure Moves Higher after Obtaining CE Mark

Accesswire April 7, 2014

Exosomes Shine a Light on Alzheimer's Disease and CTE

Accesswire April 3, 2014

Entia: An Iron-Clad Opportunity in a Billion Dollar Market

Accesswire April 2, 2014

Johnson & Johnson Enters Agreement to be Official Healthcare Partner of the USO

PR Newswire April 1, 2014

From Lab Bench to Bedside: David Lowe Brings Common Sense to Neuroscience Investing

Equities.com March 31, 2014

Decision Diagnostics Announces Posting and Airing of Its New GenStrip Commercial Titled "Monolith"

Marketwired March 31, 2014

Decision Diagnostics Announces Posting and Airing of Its New GenStrip Commercial Titled "Monolith"

Marketwired March 31, 2014

Johnson & Johnson Announces Acceptance Of Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics

PR Newswire March 31, 2014

VisionCare Announces Management Promotions

PR Newswire March 28, 2014

Johnson & Johnson to Webcast Annual Meeting of Shareholders

PR Newswire March 21, 2014

Janssen Investigational Treatment for Schizophrenia Shows Positive Efficacy, Delays Relapse

PR Newswire March 20, 2014

Philadelphia Jury Awards $3 Million in Topamax Birth Defect Trial

PR Newswire March 14, 2014

Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results

PR Newswire March 11, 2014

Pharma-Biotech Industry Helps Drive $14.4 Billion Industrial Project Activity in Massachusetts, an Industrial Info News Alert

Marketwired March 10, 2014

Intact Vascular, Inc. Hires Joseph Griffin as Vice President of Regulatory Affairs and Quality Assurance

Business Wire February 26, 2014

Biosense Webster Receives FDA Approval for First Catheter Ablation Therapy in the U.S. to Feature Direct Contact Force Technology for Treatment of Atrial Fibrillation

Business Wire February 25, 2014

Johnson & Johnson to Participate in 2014 Cowen 34th Annual Health Care Conference

PR Newswire February 25, 2014

Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension

Business Wire February 21, 2014